262 related articles for article (PubMed ID: 30305543)
1. [Hematopoietic stem cell transplantation in the era of new molecular-targeted therapies].
Kato K
Rinsho Ketsueki; 2018; 59(10):2334-2342. PubMed ID: 30305543
[TBL] [Abstract][Full Text] [Related]
2. [Molecular-targeted therapy and its impact on post-transplant immunity].
Kato K
Rinsho Ketsueki; 2018; 59(5):557-565. PubMed ID: 29877247
[TBL] [Abstract][Full Text] [Related]
3. The use of second allogeneic hematopoietic stem cell transplantation for hematologic malignancies relapsed after the first: Does it worth to do?
Göksoy HS; Arat M
Transfus Apher Sci; 2016 Feb; 54(1):91-8. PubMed ID: 26976480
[TBL] [Abstract][Full Text] [Related]
4. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
[TBL] [Abstract][Full Text] [Related]
5. [Graft versus host disease and cytokines].
Itoh T
Nihon Rinsho; 2003 Sep; 61(9):1504-11. PubMed ID: 14515716
[TBL] [Abstract][Full Text] [Related]
6. New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?
Patriarca F; Giaccone L; Onida F; Castagna L; Sarina B; Montefusco V; Mussetti A; Mordini N; Maino E; Greco R; Peccatori J; Festuccia M; Zaja F; Volpetti S; Risitano A; Bassan R; Corradini P; Ciceri F; Fanin R; Baccarani M; Rambaldi A; Bonifazi F; Bruno B
Expert Opin Biol Ther; 2017 Jul; 17(7):821-836. PubMed ID: 28506131
[TBL] [Abstract][Full Text] [Related]
7. [Hematopoietic stem cell transplantation in the era of molecular targeted therapy].
Mineishi S
Rinsho Ketsueki; 2017; 58(10):2135-2140. PubMed ID: 28978858
[TBL] [Abstract][Full Text] [Related]
8. The role of invariant NKT cells in allogeneic hematopoietic stem cell transplantation.
Karadimitris A; Chaidos A
Crit Rev Immunol; 2012; 32(2):157-71. PubMed ID: 23216613
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation].
Chen Y; Xu Y; Zhu Y; Fu G; Liu Y; Peng J; Fu B; He Q; Wu D; Li X; Zhao X; Chen F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):859-64. PubMed ID: 21946205
[TBL] [Abstract][Full Text] [Related]
10. The cell composition of infused donor lymphocyte has different impact in different types of allogeneic hematopoietic stem cell transplantation.
Zhao XS; Wang Y; Yan CH; Wang JZ; Zhang XH; Xu LP; Liu KY; Huang XJ
Clin Transplant; 2014 Aug; 28(8):926-34. PubMed ID: 24931494
[TBL] [Abstract][Full Text] [Related]
11. New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT.
Chang X; Zang X; Xia CQ
Bone Marrow Transplant; 2016 Mar; 51(3):324-32. PubMed ID: 26595077
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies.
Liu J; Zhong JF; Zhang X; Zhang C
J Hematol Oncol; 2017 Jan; 10(1):35. PubMed ID: 28143567
[TBL] [Abstract][Full Text] [Related]
13. [The safety of decitabine as bridging pretreatment regimen before hematopoietic stem cell transplantation in pediatric hematological malignancies].
Fan LY; Hu SY; Xiao PF; Lu J; Li J; Yao YH; Ling J; Kong LJ; Liu H; Bian XN
Zhonghua Nei Ke Za Zhi; 2018 Sep; 57(9):679-682. PubMed ID: 30180454
[TBL] [Abstract][Full Text] [Related]
14. Optimizing allogeneic grafts in hematopoietic stem cell transplantation.
Xu ZL; Huang XJ
Stem Cells Transl Med; 2021 Nov; 10 Suppl 2(Suppl 2):S41-S47. PubMed ID: 34724721
[TBL] [Abstract][Full Text] [Related]
15. No effect of HLA-C mismatch after allogeneic hematopoietic stem cell transplantation with unrelated donors and T-cell depletion in patients with hematological malignancies.
Magalhaes I; Uhlin M; Schaffer M; Sundin M; Hauzenberger D; Remberger M; Mattsson J
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28510343
[TBL] [Abstract][Full Text] [Related]
16. [Detection of ATP Level in CD4
Li L; Liu Y; Liu JX; Zhao DF; Zheng PH; Yin WJ; Ma YY; Qian LR; Wang HX; Gao CJ; Shen JL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1781-1786. PubMed ID: 29262916
[TBL] [Abstract][Full Text] [Related]
17. A promising sword of tomorrow: Human γδ T cell strategies reconcile allo-HSCT complications.
Hu Y; Cui Q; Luo C; Luo Y; Shi J; Huang H
Blood Rev; 2016 May; 30(3):179-88. PubMed ID: 26654098
[TBL] [Abstract][Full Text] [Related]
18. Adoptive Immunotherapies After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies.
Xiong Y; Bensoussan D; Decot V
Transfus Med Rev; 2015 Oct; 29(4):259-67. PubMed ID: 26282736
[TBL] [Abstract][Full Text] [Related]
19. [Immune checkpoint inhibitors and allogeneic hematopoietic stem cell transplantation].
Kondo E; Maeda Y
Rinsho Ketsueki; 2017; 58(5):506-513. PubMed ID: 28592767
[TBL] [Abstract][Full Text] [Related]
20. The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond.
Tsirigotis P; Shimoni A; Nagler A
Ann Med; 2014 Sep; 46(6):384-96. PubMed ID: 24888385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
